Drug stocks sluggish; Roche falls

Drug stocks are sluggish in early trading, while shares of Roche fall on news that a study for its oncology drug Avastin failed to show it was effective in treating advanced stomach cancer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.